Topiramat (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Topiramat" in Polish language version.

refsWebsite

Global rank Polish rank

32nih.gov

4^th place

7^th place

29doi.org

2^nd place

6^th place

5fda.gov

447^th place

1,118^th place

2web.archive.org

1^st place

1drugbank.ca

4,294^th place

205^th place

1patents.google.com

1,182^nd place

2,419^th place

1tga.gov.au

3,984^th place

low place

1medscape.com

719^th place

1,030^th place

1topamax.com

low place

1rxlist.com

7,927^th place

6,308^th place

doi.org

dx.doi.org

Bruce E.B.E. Maryanoff Bruce E.B.E. i inni, Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate and related compounds, „Journal of Medicinal Chemistry”, 30 (5), 1987, s. 880–887, DOI: 10.1021/jm00388a023, PMID: 3572976 [dostęp 2023-07-25] (ang.).
Bruce E.B.E. Maryanoff Bruce E.B.E. i inni, Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives, „Journal of Medicinal Chemistry”, 41 (8), 1998, s. 1315–1343, DOI: 10.1021/jm970790w, PMID: 9548821 [dostęp 2023-07-25] (ang.).
DaniloD. Arnone DaniloD., D Arnone. Review of the use of Topiramate for treatment of psychiatric disorders, „Annals of General Psychiatry”, 4 (1), 2005, s. 5, DOI: 10.1186/1744-859X-4-5, PMID: 15845141, PMCID: PMC1088011 [dostęp 2023-07-25] (ang.).
KatieK. Pigott KatieK. i inni, Topiramate for acute affective episodes in bipolar disorder in adults, „Cochrane Database of Systematic Reviews”, 2016 (9), 2016, art. nr CD003384, DOI: 10.1002/14651858.CD003384.pub3, PMID: 27591453, PMCID: PMC6457604 [dostęp 2023-07-25] (ang.).
AndreaA. Cipriani AndreaA. i inni, Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, „The Lancet”, 378 (9799), 2011, s. 1306–1315, DOI: 10.1016/S0140-6736(11)60873-8, PMID: 21851976 [dostęp 2023-07-25] (ang.).
KlausK. Lieb KlausK. i inni, Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials, „British Journal of Psychiatry”, 196 (1), 2010, s. 4–12, DOI: 10.1192/bjp.bp.108.062984, PMID: 20044651 [dostęp 2023-07-25] (ang.).
Bankole A.B.A. Johnson Bankole A.B.A., NassimaN. Ait-Daoud NassimaN., Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients, „Current Pharmaceutical Design”, 16 (19), 2010, s. 2103–2112, DOI: 10.2174/138161210791516404, PMID: 20482511, PMCID: PMC3063512 [dostęp 2023-07-25] (ang.).
Kyle M.K.M. Kampman Kyle M.K.M. i inni, A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence, „Drug and Alcohol Dependence”, 133 (1), 2013, s. 94–99, DOI: 10.1016/j.drugalcdep.2013.05.026, PMID: 23810644, PMCID: PMC3786029 [dostęp 2023-07-25] (ang.).
Ann K.A.K. Shinn Ann K.A.K., Shelly F.S.F. Greenfield Shelly F.S.F., Topiramate in the Treatment of Substance-Related Disorders: A Critical Review of the Literature, „The Journal of Clinical Psychiatry”, 71 (05), 2010, s. 634–648, DOI: 10.4088/JCP.08r04062gry, PMID: 20361908, PMCID: PMC3736141 [dostęp 2023-07-25] (ang.).
AlbertoA. Verrotti AlbertoA. i inni, Topiramate-induced weight loss: A review, „Epilepsy Research”, 95 (3), 2011, s. 189–199, DOI: 10.1016/j.eplepsyres.2011.05.014, PMID: 21684121 [dostęp 2023-07-25] (ang.).
C.K.C.K. Kramer C.K.C.K. i inni, Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials: Topiramate and weight loss, „Obesity Reviews”, 12 (5), 2011, e338–e347, DOI: 10.1111/j.1467-789X.2010.00846.x, PMID: 21438989 [dostęp 2023-07-25] (ang.).
Margaret K.M.K. Hahn Margaret K.M.K. i inni, Topiramate in Schizophrenia: A Review of Effects on Psychopathology and Metabolic Parameters, „Clinical Schizophrenia & Related Psychoses”, 6 (4), 2013, s. 186–196, DOI: 10.3371/CSRP.HACO.01062013, PMID: 23302448 [dostęp 2023-07-25] (ang.).
ShamailS. Mahmood ShamailS. i inni, Effect of Topiramate on Weight Gain in Patients Receiving Atypical Antipsychotic Agents, „Journal of Clinical Psychopharmacology”, 33 (1), 2013, s. 90–94, DOI: 10.1097/JCP.0b013e31827cb2b7, PMID: 23277264 [dostęp 2023-07-25] (ang.).
MattiasM. Linde MattiasM. i inni, Topiramate for the prophylaxis of episodic migraine in adults, „Cochrane Database of Systematic Reviews”, 2013, art. nr CD010610, DOI: 10.1002/14651858.CD010610, PMID: 23797676, PMCID: PMC7388931 [dostęp 2023-07-25] (ang.).
AnnaA. Ferrari AnnaA. i inni, Clinical pharmacology of topiramate in migraine prevention, „Expert Opinion on Drug Metabolism & Toxicology”, 7 (9), 2011, s. 1169–1181, DOI: 10.1517/17425255.2011.602067, PMID: 21756204 [dostęp 2023-07-25] (ang.).
Pamela L.P.L. Follett Pamela L.P.L. i inni, Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate, „Journal of Neuroscience”, 24 (18), 2004, s. 4412–4420, DOI: 10.1523/JNEUROSCI.0477-04.2004, PMID: 15128855 .
Miranda RM.R. Andrus Miranda RM.R., ElizabethE. Gilbert ElizabethE., Treatment of Civilian and Combat-Related Posttraumatic Stress Disorder with Topiramate, „Annals of Pharmacotherapy”, 44 (11), 2010, s. 1810–1816, DOI: 10.1345/aph.1P163, PMID: 11552774 [dostęp 2023-07-25] (ang.).
Scott P.S.P. Hoopes Scott P.S.P. i inni, Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures, „The Journal of Clinical Psychiatry”, 64 (11), 2003, s. 1335–1341, DOI: 10.4088/JCP.v64n1109, PMID: 14658948 [dostęp 2023-07-25] (ang.).
YasserY. Khazaal YasserY. i inni, Topiramate for smoking cessation, „Psychiatry and Clinical Neurosciences”, 60 (3), 2006, s. 384–388, DOI: 10.1111/j.1440-1819.2006.01518.x, PMID: 16732758 [dostęp 2023-07-25] (ang.).
N.N. Çelebisoy N.N. i inni, Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study, „Acta Neurologica Scandinavica”, 116 (5), 2007, s. 322–327, DOI: 10.1111/j.1600-0404.2007.00905.x, PMID: 17922725 [dostęp 2023-07-25] (ang.).
Miguel J.A.M.J.A. Láinez Miguel J.A.M.J.A. i inni, Topiramate in the Prophylactic Treatment of Cluster Headache, „Headache: The Journal of Head and Face Pain”, 43 (7), 2003, s. 784–789, DOI: 10.1046/j.1526-4610.2003.03137.x, PMID: 12890134 [dostęp 2023-07-25] (ang.).
Philip JP.J. Wiffen Philip JP.J. i inni, Topiramate for neuropathic pain and fibromyalgia in adults, „Cochrane Database of Systematic Reviews”, 2013, art. nr CD008314, DOI: 10.1002/14651858.cd008314.pub3, PMID: 23996081, PMCID: PMC8406931 [dostęp 2023-07-25] (ang.).
D.D. Blum D.D. i inni, Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy, „Neurology”, 67 (3), 2006, s. 400–406, DOI: 10.1212/01.wnl.0000232737.72555.06, PMID: 16894098 [dostęp 2023-07-25] (ang.).
NasirN. Mirza NasirN., Anthony G.A.G. Marson Anthony G.A.G., MunirM. Pirmohamed MunirM., Effect of topiramate on acid-base balance: extent, mechanism and effects: Topiramate and acid-base balance, „British Journal of Clinical Pharmacology”, 68 (5), 2009, s. 655–661, DOI: 10.1111/j.1365-2125.2009.03521.x, PMID: 19916989, PMCID: PMC2791971 [dostęp 2023-07-25] (ang.).
S.S. Hunt S.S. i inni, Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register, „Neurology”, 71 (4), 2008, s. 272–276, DOI: 10.1212/01.wnl.0000318293.28278.33, PMID: 18645165 [dostęp 2023-07-25] (ang.).
ChristianCh. Brandt ChristianCh. i inni, Topiramate overdose: A case report of a patient with extremely high topiramate serum concentrations and nonconvulsive status epilepticus: TPM Overdose with Very High Serum Levels, „Epilepsia”, 51 (6), 2009, s. 1090–1093, DOI: 10.1111/j.1528-1167.2009.02395.x, PMID: 19889015 [dostęp 2023-07-25] (ang.).
Alexei P.A.P. Kudin Alexei P.A.P. i inni, The Mechanism of Neuroprotection by Topiramate in an Animal Model of Epilepsy, „Epilepsia”, 45 (12), 2004, s. 1478–1487, DOI: 10.1111/j.0013-9580.2004.13504.x, PMID: 15571505 [dostęp 2023-07-25] (ang.).

doi.org

MR Andrus, Gilbert, E. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate. „The Annals of Pharmacotherapy”. 44 (11), s. 1810–1816, November 2010. DOI: 10.1345/aph.1P163. PMID: 20923947.
TA Glauser, PO Clark, R Strawsburg. A pilot study of topiramate in the treatment of infantile spasms. „Epilepsia”. 39 (12), s. 1324–1328, 1998. DOI: 10.1111/j.1528-1157.1998.tb01331.x. PMID: 9860068.

drugbank.ca

Topiramate, [w:] DrugBank [online], University of Alberta, DB00273 (ang.).

fda.gov

http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/UCM173936.pdf.
Suicidality and Antiepileptic Drugs. [dostęp 2013-07-11].
Report a Serious Problem: FDA Drug Safety Communication: Risk of oral clefts in children born to mothers taking Topamax (topiramate). Fda.gov, 2011-01-06. [dostęp 2013-07-11].
http://www.fda.gov/Safety/MedWatch/SafetyInformation/ucm195797.htm.

accessdata.fda.gov

TOPAMAX^® (topiramate) Tablets. TOPAMAX^® (topiramate capsules) Sprinkle Capsules, FDA, 29 czerwca 2005, s. 13–14 [dostęp 2023-07-26] (ang.).

medscape.com

reference.medscape.com

topiramate (Rx) – Topamax, Trokendi XR. [w:] Medscape Reference [on-line]. WebMD. [dostęp 2013-11-18].

nih.gov

ncbi.nlm.nih.gov

Bruce E.B.E. Maryanoff Bruce E.B.E. i inni, Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-β-D-fructopyranose sulfamate and related compounds, „Journal of Medicinal Chemistry”, 30 (5), 1987, s. 880–887, DOI: 10.1021/jm00388a023, PMID: 3572976 [dostęp 2023-07-25] (ang.).
Bruce E.B.E. Maryanoff Bruce E.B.E. i inni, Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives, „Journal of Medicinal Chemistry”, 41 (8), 1998, s. 1315–1343, DOI: 10.1021/jm970790w, PMID: 9548821 [dostęp 2023-07-25] (ang.).
DaniloD. Arnone DaniloD., D Arnone. Review of the use of Topiramate for treatment of psychiatric disorders, „Annals of General Psychiatry”, 4 (1), 2005, s. 5, DOI: 10.1186/1744-859X-4-5, PMID: 15845141, PMCID: PMC1088011 [dostęp 2023-07-25] (ang.).
KatieK. Pigott KatieK. i inni, Topiramate for acute affective episodes in bipolar disorder in adults, „Cochrane Database of Systematic Reviews”, 2016 (9), 2016, art. nr CD003384, DOI: 10.1002/14651858.CD003384.pub3, PMID: 27591453, PMCID: PMC6457604 [dostęp 2023-07-25] (ang.).
AndreaA. Cipriani AndreaA. i inni, Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis, „The Lancet”, 378 (9799), 2011, s. 1306–1315, DOI: 10.1016/S0140-6736(11)60873-8, PMID: 21851976 [dostęp 2023-07-25] (ang.).
KlausK. Lieb KlausK. i inni, Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials, „British Journal of Psychiatry”, 196 (1), 2010, s. 4–12, DOI: 10.1192/bjp.bp.108.062984, PMID: 20044651 [dostęp 2023-07-25] (ang.).
Bankole A.B.A. Johnson Bankole A.B.A., NassimaN. Ait-Daoud NassimaN., Topiramate in the New Generation of Drugs: Efficacy in the Treatment of Alcoholic Patients, „Current Pharmaceutical Design”, 16 (19), 2010, s. 2103–2112, DOI: 10.2174/138161210791516404, PMID: 20482511, PMCID: PMC3063512 [dostęp 2023-07-25] (ang.).
Kyle M.K.M. Kampman Kyle M.K.M. i inni, A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence, „Drug and Alcohol Dependence”, 133 (1), 2013, s. 94–99, DOI: 10.1016/j.drugalcdep.2013.05.026, PMID: 23810644, PMCID: PMC3786029 [dostęp 2023-07-25] (ang.).
Ann K.A.K. Shinn Ann K.A.K., Shelly F.S.F. Greenfield Shelly F.S.F., Topiramate in the Treatment of Substance-Related Disorders: A Critical Review of the Literature, „The Journal of Clinical Psychiatry”, 71 (05), 2010, s. 634–648, DOI: 10.4088/JCP.08r04062gry, PMID: 20361908, PMCID: PMC3736141 [dostęp 2023-07-25] (ang.).
AlbertoA. Verrotti AlbertoA. i inni, Topiramate-induced weight loss: A review, „Epilepsy Research”, 95 (3), 2011, s. 189–199, DOI: 10.1016/j.eplepsyres.2011.05.014, PMID: 21684121 [dostęp 2023-07-25] (ang.).
C.K.C.K. Kramer C.K.C.K. i inni, Efficacy and safety of topiramate on weight loss: a meta-analysis of randomized controlled trials: Topiramate and weight loss, „Obesity Reviews”, 12 (5), 2011, e338–e347, DOI: 10.1111/j.1467-789X.2010.00846.x, PMID: 21438989 [dostęp 2023-07-25] (ang.).
Margaret K.M.K. Hahn Margaret K.M.K. i inni, Topiramate in Schizophrenia: A Review of Effects on Psychopathology and Metabolic Parameters, „Clinical Schizophrenia & Related Psychoses”, 6 (4), 2013, s. 186–196, DOI: 10.3371/CSRP.HACO.01062013, PMID: 23302448 [dostęp 2023-07-25] (ang.).
ShamailS. Mahmood ShamailS. i inni, Effect of Topiramate on Weight Gain in Patients Receiving Atypical Antipsychotic Agents, „Journal of Clinical Psychopharmacology”, 33 (1), 2013, s. 90–94, DOI: 10.1097/JCP.0b013e31827cb2b7, PMID: 23277264 [dostęp 2023-07-25] (ang.).
MattiasM. Linde MattiasM. i inni, Topiramate for the prophylaxis of episodic migraine in adults, „Cochrane Database of Systematic Reviews”, 2013, art. nr CD010610, DOI: 10.1002/14651858.CD010610, PMID: 23797676, PMCID: PMC7388931 [dostęp 2023-07-25] (ang.).
AnnaA. Ferrari AnnaA. i inni, Clinical pharmacology of topiramate in migraine prevention, „Expert Opinion on Drug Metabolism & Toxicology”, 7 (9), 2011, s. 1169–1181, DOI: 10.1517/17425255.2011.602067, PMID: 21756204 [dostęp 2023-07-25] (ang.).
MR Andrus, Gilbert, E. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate. „The Annals of Pharmacotherapy”. 44 (11), s. 1810–1816, November 2010. DOI: 10.1345/aph.1P163. PMID: 20923947.
TA Glauser, PO Clark, R Strawsburg. A pilot study of topiramate in the treatment of infantile spasms. „Epilepsia”. 39 (12), s. 1324–1328, 1998. DOI: 10.1111/j.1528-1157.1998.tb01331.x. PMID: 9860068.
Pamela L.P.L. Follett Pamela L.P.L. i inni, Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate, „Journal of Neuroscience”, 24 (18), 2004, s. 4412–4420, DOI: 10.1523/JNEUROSCI.0477-04.2004, PMID: 15128855 .
Miranda RM.R. Andrus Miranda RM.R., ElizabethE. Gilbert ElizabethE., Treatment of Civilian and Combat-Related Posttraumatic Stress Disorder with Topiramate, „Annals of Pharmacotherapy”, 44 (11), 2010, s. 1810–1816, DOI: 10.1345/aph.1P163, PMID: 11552774 [dostęp 2023-07-25] (ang.).
Scott P.S.P. Hoopes Scott P.S.P. i inni, Treatment of Bulimia Nervosa With Topiramate in a Randomized, Double-Blind, Placebo-Controlled Trial, Part 1: Improvement in Binge and Purge Measures, „The Journal of Clinical Psychiatry”, 64 (11), 2003, s. 1335–1341, DOI: 10.4088/JCP.v64n1109, PMID: 14658948 [dostęp 2023-07-25] (ang.).
YasserY. Khazaal YasserY. i inni, Topiramate for smoking cessation, „Psychiatry and Clinical Neurosciences”, 60 (3), 2006, s. 384–388, DOI: 10.1111/j.1440-1819.2006.01518.x, PMID: 16732758 [dostęp 2023-07-25] (ang.).
N.N. Çelebisoy N.N. i inni, Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study, „Acta Neurologica Scandinavica”, 116 (5), 2007, s. 322–327, DOI: 10.1111/j.1600-0404.2007.00905.x, PMID: 17922725 [dostęp 2023-07-25] (ang.).
Miguel J.A.M.J.A. Láinez Miguel J.A.M.J.A. i inni, Topiramate in the Prophylactic Treatment of Cluster Headache, „Headache: The Journal of Head and Face Pain”, 43 (7), 2003, s. 784–789, DOI: 10.1046/j.1526-4610.2003.03137.x, PMID: 12890134 [dostęp 2023-07-25] (ang.).
Philip JP.J. Wiffen Philip JP.J. i inni, Topiramate for neuropathic pain and fibromyalgia in adults, „Cochrane Database of Systematic Reviews”, 2013, art. nr CD008314, DOI: 10.1002/14651858.cd008314.pub3, PMID: 23996081, PMCID: PMC8406931 [dostęp 2023-07-25] (ang.).
D.D. Blum D.D. i inni, Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy, „Neurology”, 67 (3), 2006, s. 400–406, DOI: 10.1212/01.wnl.0000232737.72555.06, PMID: 16894098 [dostęp 2023-07-25] (ang.).
NasirN. Mirza NasirN., Anthony G.A.G. Marson Anthony G.A.G., MunirM. Pirmohamed MunirM., Effect of topiramate on acid-base balance: extent, mechanism and effects: Topiramate and acid-base balance, „British Journal of Clinical Pharmacology”, 68 (5), 2009, s. 655–661, DOI: 10.1111/j.1365-2125.2009.03521.x, PMID: 19916989, PMCID: PMC2791971 [dostęp 2023-07-25] (ang.).
S.S. Hunt S.S. i inni, Topiramate in pregnancy: Preliminary experience from the UK Epilepsy and Pregnancy Register, „Neurology”, 71 (4), 2008, s. 272–276, DOI: 10.1212/01.wnl.0000318293.28278.33, PMID: 18645165 [dostęp 2023-07-25] (ang.).
ChristianCh. Brandt ChristianCh. i inni, Topiramate overdose: A case report of a patient with extremely high topiramate serum concentrations and nonconvulsive status epilepticus: TPM Overdose with Very High Serum Levels, „Epilepsia”, 51 (6), 2009, s. 1090–1093, DOI: 10.1111/j.1528-1167.2009.02395.x, PMID: 19889015 [dostęp 2023-07-25] (ang.).
Alexei P.A.P. Kudin Alexei P.A.P. i inni, The Mechanism of Neuroprotection by Topiramate in an Animal Model of Epilepsy, „Epilepsia”, 45 (12), 2004, s. 1478–1487, DOI: 10.1111/j.0013-9580.2004.13504.x, PMID: 15571505 [dostęp 2023-07-25] (ang.).
KatarzynaK. Czuczwar KatarzynaK. i inni, Neuroprotekcyjne działanie leków przeciwpadaczkowych, „Przegląd lekarski”, 61 (11), 2004, s. 1268–1271, PMID: 15727029 .

dailymed.nlm.nih.gov

TOPIRAMATE (topiramate) tablet TOPIRAMATE (topiramate) tablet [Torrent Pharmaceuticals Limited]. [w:] DailyMed [on-line]. Torrent Pharmaceuticals Limited, August 2011. [dostęp 2013-11-18].

nlm.nih.gov

„Topomax side effects”: https://web.archive.org/web/20110128083201/http://www.topamax.com/how-topamax-may-help--what-to-expect.html (retrieved Jan 6 2011)' „Migraine prevention medicine: Topomax”: http://www.topamax.com/ (retrieved Jan 6 2011); NIH Pubmed Health, „Topiramate”: https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697012.html (dostęp 2016-03-30).

patents.google.com

Anticonvulsant sulfamate derivatives, wynalazca: Bruce E.B.E. Maryanoff, Joseph F.J.F. Gardocki, patent US 4513006, 23 kwietnia 1985 (ang.).

rxlist.com

Topamax (Topiramate) Drug Information: Description, User Reviews, Drug Side Effects, Interactions – Prescribing Information at RxList. Rxlist.com, 2012-11-09. [dostęp 2013-07-11].

tga.gov.au

ebs.tga.gov.au

TOPAMAX^® Tablets and Sprinkle Capsules product information. [w:] TGA eBusiness Services [on-line]. Janssen-Cilag Pty Ltd, 30 maja 2013. [dostęp 2013-11-18].

topamax.com

„Topomax side effects”: https://web.archive.org/web/20110128083201/http://www.topamax.com/how-topamax-may-help--what-to-expect.html (retrieved Jan 6 2011)' „Migraine prevention medicine: Topomax”: http://www.topamax.com/ (retrieved Jan 6 2011); NIH Pubmed Health, „Topiramate”: https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697012.html (dostęp 2016-03-30).

web.archive.org

Topiramate 100 mg film-coated Tablets, [w:] electronic Medicines Compendium [online], Sandoz Limited, 6 marca 2013 [zarchiwizowane 2014-05-21] .
„Topomax side effects”: https://web.archive.org/web/20110128083201/http://www.topamax.com/how-topamax-may-help--what-to-expect.html (retrieved Jan 6 2011)' „Migraine prevention medicine: Topomax”: http://www.topamax.com/ (retrieved Jan 6 2011); NIH Pubmed Health, „Topiramate”: https://www.nlm.nih.gov/medlineplus/druginfo/meds/a697012.html (dostęp 2016-03-30).